Marcusso, R.M.d.N.; Assone, T.; Haziot, M.E.; Smid, J.; Folgosi, V.A.; Rosadas, C.; Casseb, J.; de Oliveira, A.C.P.; the HTLV-1 Clinical Definition Working Group.
HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients. Pathogens 2024, 13, 403.
https://doi.org/10.3390/pathogens13050403
AMA Style
Marcusso RMdN, Assone T, Haziot ME, Smid J, Folgosi VA, Rosadas C, Casseb J, de Oliveira ACP, the HTLV-1 Clinical Definition Working Group.
HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients. Pathogens. 2024; 13(5):403.
https://doi.org/10.3390/pathogens13050403
Chicago/Turabian Style
Marcusso, Rosa Maria do Nascimento, Tatiane Assone, Michel E. Haziot, Jerusa Smid, Victor A. Folgosi, Carolina Rosadas, Jorge Casseb, Augusto C. Penalva de Oliveira, and the HTLV-1 Clinical Definition Working Group.
2024. "HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients" Pathogens 13, no. 5: 403.
https://doi.org/10.3390/pathogens13050403
APA Style
Marcusso, R. M. d. N., Assone, T., Haziot, M. E., Smid, J., Folgosi, V. A., Rosadas, C., Casseb, J., de Oliveira, A. C. P., & the HTLV-1 Clinical Definition Working Group.
(2024). HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients. Pathogens, 13(5), 403.
https://doi.org/10.3390/pathogens13050403
